Table 3 Predictive factors of clinical response (>50%) according to univariate and multivariate analyses
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
N | CR (%) | P | RR (IC 95%) | P | RR (IC 95%) | |
Age | ||||||
 >40 | 548 | 58 | 1 | |||
 ⩽40 | 138 | 55 | 0.6 | 0.9 (0.6–1.3) | ||
Menopause | ||||||
 No | 512 | 56 | ||||
 Yes | 174 | 61 | 0.3 | 1.2 (0.8–1.7) | ||
Clinical tumour stage | ||||||
 cT2 | 515 | 60 | ||||
 cT3 | 171 | 51 | <0.05a | 0.7 (0.5–0.99) | 0.12 | 0.7 (0.5–1.1) |
Clinical nodal status | ||||||
 cN0 | 425 | 56 | ||||
 cN1 | 261 | 60 | 0.3 | 1.2 (0.9–1.6) | ||
Histological type | ||||||
 Ductal | 617 | 59 | ||||
 Lobular | 69 | 43 | 0.02 | 0.5 (0.3–0.9) | 0.23 | 0.7 (0.4–1.3) |
Hormonal receptors b | ||||||
 HR+ | 433 | 55 | ||||
 HR− | 144 | 65 | 0.03 | 1.5 (1.0–2.3) | 0.09 | 1.4 (0.9–2.1) |
Histological grade | ||||||
 Grade 1 | 113 | 42 | 1 | 1 | ||
 Grade 2 | 360 | 59 | 0.003 | 1.9 (1.3–3.0) | 0.02 | 1.8 (1.1–3.0) |
 Grade 3 | 213 | 63 | <10−3 | 2.3 (1.4–3.7) | 0.02 | 2.0 (1.1–3.4) |